Reducing maternal deaths from obstructed labor
PREVENTING MATERNAL MORTALITY FROM OBSTRUCTED LABOR
This study is creating a helpful mobile app for healthcare workers in Ethiopia to better monitor and support pregnant women who might face difficulties during labor, aiming to improve their health and safety.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11065518 on NIH RePORTER |
What this research studies
This research focuses on addressing the issue of obstructed labor, a significant cause of maternal mortality, particularly in low-resource settings like Ethiopia. It aims to develop and implement a mobile phone application that will help medical personnel accurately assess and monitor pregnant women at risk of cephalopelvic disproportion (CPD). By improving antenatal care and facilitating timely access to surgical interventions, the project seeks to enhance maternal health outcomes. The study will involve collecting data on maternal nutrition and health to better understand the factors contributing to obstructed labor.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant women in low-resource areas, particularly those at risk of obstructed labor due to factors like malnutrition or young age.
Not a fit: Patients who are not pregnant or those in high-resource settings may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce maternal mortality rates associated with obstructed labor by improving access to timely medical care.
How similar studies have performed: Other research has shown success in using mobile health technologies to improve maternal health outcomes, indicating that this approach has potential.
Where this research is happening
Atlanta, United States
- Georgia Institute of Technology — Atlanta, United States (Active)
Researchers
- Principal investigator: Gleason, Rudolph L — Georgia Institute of Technology
- Study coordinator: Gleason, Rudolph L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.